| |
| |
|
| Insider
Information: |
Gustafson Kurt A |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
535,630 |
|
|
Indirect Shares
|
11,840 |
|
|
| Direct
Value |
$2,614,075 |
|
|
|
Indirect Value
|
$12,195 |
|
|
| Total
Shares |
547,470 |
|
|
| Total
Value |
$2,626,271 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-3.0
|
| Percentage
Gain/Loss : |
 103.1%
|
 -53.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
Vice President and CFO |
2013-02-02 |
35,667 |
2011-08-09 |
0 |
Premium* |
|
|
Spectrum Pharmaceuticals Inc |
SPPI |
EVP & Chief Financial ... |
2022-03-16 |
317,259 |
2022-03-16 |
11,840 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Executive VP, Finance ... |
2024-04-08 |
176,697 |
2022-11-01 |
0 |
Premium* |
|
|
Xencor Inc |
XNCR |
Director |
2024-03-06 |
6,007 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OABI |
OmniAb, Inc |
Executive VP, Finance and CFO |
• – – |
2024-04-08 |
4 |
S |
$5.27 |
$36,648 |
D/D |
(6,954) |
176,697 |
0 |
% |
|
| OABI |
OmniAb, Inc |
Executive VP, Finance and CFO |
• – – |
2024-04-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,541 |
183,651 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Executive VP, Finance & CFO |
• – – |
2024-04-01 |
4 |
S |
$5.46 |
$64,696 |
D/D |
(11,849) |
170,110 |
0 |
% |
|
| OABI |
OmniAb, Inc |
Executive VP, Finance & CFO |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,254 |
181,959 |
0 |
- |
|
| XNCR |
Xencor Inc |
Director |
• • – |
2024-03-06 |
4 |
S |
$23.18 |
$324,453 |
D/D |
(14,000) |
6,007 |
0 |
% |
|
| XNCR |
Xencor Inc |
Director |
• • – |
2024-03-06 |
4 |
OE |
$10.73 |
$160,950 |
D/D |
15,000 |
20,007 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Executive VP, Finance & CFO |
• – – |
2023-12-07 |
4 |
D |
$4.85 |
$77,993 |
D/D |
(16,081) |
158,705 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Executive VP, Finance & CFO |
• – – |
2023-12-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,503 |
174,786 |
0 |
- |
|
| XNCR |
Xencor Inc |
Director |
• • – |
2023-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,007 |
5,007 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Executive VP, Finance & CFO |
• – – |
2023-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
40,625 |
335,416 |
0 |
- |
|
| OABI |
OmniAb, Inc |
EVP, Finance and CFO |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
139,504 |
302,833 |
0 |
- |
|
| OABI |
OmniAb, Inc |
EVP, Finance and CFO |
• – – |
2022-12-01 |
4 |
D |
$3.35 |
$22,556 |
D/D |
(6,733) |
163,329 |
0 |
- |
|
| OABI |
OmniAb, Inc |
EVP, Finance and CFO |
• – – |
2022-11-28 |
4 |
B |
$2.81 |
$28,100 |
D/D |
10,000 |
170,062 |
2.74 |
% |
|
| OABI |
OmniAb, Inc |
EVP, Finance and CFO |
• – – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
160,062 |
160,062 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2022-03-16 |
4 |
AS |
$0.71 |
$11,521 |
D/D |
(16,318) |
317,259 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2022-03-15 |
4 |
AS |
$0.71 |
$14,560 |
D/D |
(20,653) |
333,577 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2022-02-24 |
4 |
AS |
$0.64 |
$10,213 |
D/D |
(15,958) |
354,230 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2022-02-23 |
4 |
AS |
$0.70 |
$14,211 |
D/D |
(20,215) |
366,188 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-03-16 |
4 |
AS |
$3.69 |
$60,213 |
D/D |
(16,318) |
400,451 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-03-15 |
4 |
AS |
$3.63 |
$73,823 |
D/D |
(20,365) |
416,769 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-02-22 |
4 |
AS |
$3.73 |
$14,920 |
D/D |
(4,000) |
437,134 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-02-19 |
4 |
AS |
$3.64 |
$16,992 |
D/D |
(4,672) |
441,134 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
119,579 |
445,806 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-01-20 |
4 |
AS |
$4.31 |
$8,379 |
D/D |
(1,944) |
330,608 |
0 |
% |
|
| SPPI |
Spectrum Pharmaceuticals ... |
EVP & Chief Financial Officer |
• – – |
2021-01-19 |
4 |
AS |
$3.81 |
$9,832 |
D/D |
(2,582) |
332,552 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
